The 3D Bioprinter of Prometheus guarantees a higher cell viability (>95%) after printer and beyond, instead of other machines (<65%) now available in different laboratories.

Thanks to the innovative extrusion system, we are able to control cell disposition inside the final tissue, creating functional tissue always equal one to another, even if created in different process. This aspect is really important to have more reliable data when 3D artificial tissues are used for drug testing.

Read more…